http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5856084-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36b19bce8760e32c233f01c03e6406f8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
filingDate 1995-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaa691b927fe1796e4c31dfffad31c05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce9f980a70802abba21c4d9b2151604
publicationDate 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5856084-A
titleOfInvention Hepatitis B vaccine
abstract PCT No. PCT/GB95/00208 Sec. 371 Date Dec. 28, 1995 Sec. 102(e) Date Dec. 28, 1995 PCT Filed Feb. 2, 1995 PCT Pub. No. WO95/21189 PCT Pub. Date Aug. 10, 1995A variant or so-called "escape mutant" HBsAg protein or fragment thereof displaying the antigenicity of hepatitis B virus surface antigen is disclosed, in which the mutant protein or fragment thereof (mHBsAg) comprises a modified 'a' determinant in which at least two amino acids are inserted downstream of position 122 of the wild type HBsAg sequence. A vaccine comprising the mHBsAg is provided, as is a kit for diagnostic in vitro detection of anti-mHBsAg antibodies and an antibody preparation comprising anti-mHBsAg antibodies.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9034841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9914982-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100916992-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8242238-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9677076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0157192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9127278-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008081328-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004029111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102292870-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006264604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003032008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011081645-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003129202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7785844-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9109264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194196-A1
priorityDate 1994-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5595739-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9114703-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9426904-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5593825-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0511855-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128771931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127978224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548

Total number of triples: 69.